127 related articles for article (PubMed ID: 8184123)
21. The use of small fraction numbers in high dose-rate gynaecological afterloading: some radiobiological considerations.
Dale RG
Br J Radiol; 1990 Apr; 63(748):290-4. PubMed ID: 2346867
[TBL] [Abstract][Full Text] [Related]
22. Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer.
Murray L; Mason J; Henry AM; Hoskin P; Siebert FA; Venselaar J; Bownes P;
Radiother Oncol; 2016 Aug; 120(2):293-9. PubMed ID: 27370205
[TBL] [Abstract][Full Text] [Related]
23. Dosimetric and radiobiological comparison of volumetric modulated arc therapy, high-dose rate brachytherapy, and low-dose rate permanent seeds implant for localized prostate cancer.
Yang R; Zhao N; Liao A; Wang H; Qu A
Med Dosim; 2016; 41(3):236-41. PubMed ID: 27400663
[TBL] [Abstract][Full Text] [Related]
24. Transition from LDR to HDR brachytherapy for cervical cancer: Evaluation of tumor control, survival, and toxicity.
Romano KD; Pugh KJ; Trifiletti DM; Libby B; Showalter TN
Brachytherapy; 2017; 16(2):378-386. PubMed ID: 28139420
[TBL] [Abstract][Full Text] [Related]
25. [Intracavitary brachytherapy with long and short-term afterloading technic in gynecology].
Bauer M
Gynakologe; 1987 Dec; 20(4):228-36. PubMed ID: 3325373
[No Abstract] [Full Text] [Related]
26. Point: why choose pulsed-dose-rate brachytherapy for treating gynecologic cancers?
Davidson SE; Hendry JH; West CM
Brachytherapy; 2009; 8(3):269-72. PubMed ID: 19643373
[No Abstract] [Full Text] [Related]
27. A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy.
Vargas C; Ghilezan M; Hollander M; Gustafson G; Korman H; Gonzalez J; Martinez A
J Urol; 2005 Sep; 174(3):882-7. PubMed ID: 16093980
[TBL] [Abstract][Full Text] [Related]
28. Current controversies in high-dose-rate versus low-dose-rate brachytherapy for cervical cancer.
Stewart AJ; Viswanathan AN
Cancer; 2006 Sep; 107(5):908-15. PubMed ID: 16874815
[TBL] [Abstract][Full Text] [Related]
29. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
[TBL] [Abstract][Full Text] [Related]
30. [Brachytherapy in paediatric sarcoma].
Haie-Meder C; Martelli H; Dumas I; Mazeron R; Oberlin O
Bull Cancer; 2011 May; 98(5):549-57. PubMed ID: 21609896
[TBL] [Abstract][Full Text] [Related]
31. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.
Pos FJ; Horenblas S; Lebesque J; Moonen L; Schneider C; Sminia P; Bartelink H
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):696-705. PubMed ID: 15183473
[TBL] [Abstract][Full Text] [Related]
32. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds.
Grills IS; Martinez AA; Hollander M; Huang R; Goldman K; Chen PY; Gustafson GS
J Urol; 2004 Mar; 171(3):1098-104. PubMed ID: 14767279
[TBL] [Abstract][Full Text] [Related]
33. [Gynecologic intracavity brachytherapy of a high-dose intensity. A review of the literature].
Bistolfi F; Papadia S; Scielzo G; Siragusa A; Leonardi S; Tomassini E; Grillo Ruggieri F; Guglielmi M; Brizzi C; Parietti E
Radiol Med; 1988 Oct; 76(4):347-55. PubMed ID: 3055080
[No Abstract] [Full Text] [Related]
34. Case report: low dose rate and high dose rate intracavitary brachytherapy in a patient with carcinoma of the cervix.
Tan LT; Jones B; Freestone G; Dale RG
Br J Radiol; 1996 Jan; 69(817):84-6. PubMed ID: 8785631
[TBL] [Abstract][Full Text] [Related]
35. [The therapeutic dosage play room in short term afterloading therapy in gynecology].
Busch M
Strahlentherapie Sonderb; 1981; 76():320-7. PubMed ID: 7303118
[No Abstract] [Full Text] [Related]
36. Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a propensity score matched analysis.
Smith GD; Pickles T; Crook J; Martin AG; Vigneault E; Cury FL; Morris J; Catton C; Lukka H; Warner A; Yang Y; Rodrigues G
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):505-16. PubMed ID: 25596107
[TBL] [Abstract][Full Text] [Related]
37. From low-dose-rate to high-dose-rate brachytherapy in lip carcinoma: Equivalent results but fewer complications.
Guinot JL; Arribas L; Tortajada MI; Crispín V; Carrascosa M; Santos M; Mut A; Vendrell JB; Pesudo C; Chust ML
Brachytherapy; 2013; 12(6):528-34. PubMed ID: 23850275
[TBL] [Abstract][Full Text] [Related]
38. Determination of the appropriate fraction number and size of the HDR brachytherapy for cervical cancer.
Liu WS; Yen SH; Chang CH; Yang KM; Wu YP; Chen KY
Gynecol Oncol; 1996 Feb; 60(2):295-300. PubMed ID: 8631555
[TBL] [Abstract][Full Text] [Related]
39. High dose rate versus low dose rate brachytherapy for squamous cell carcinoma of the cervix: an economic analysis.
Jones G; Lukka H; O'Brien B
Br J Radiol; 1994 Nov; 67(803):1113-20. PubMed ID: 7820405
[TBL] [Abstract][Full Text] [Related]
40. A fast planning program for interstitial and gynaecological use.
Krieger H
Sonderb Strahlenther Onkol; 1988; 82():72-7. PubMed ID: 3394006
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
